{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:56:17Z","timestamp":1776747377219,"version":"3.51.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11060-019-03340-7","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T16:02:44Z","timestamp":1573747364000},"page":"91-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Hypofractionated radiotherapy with temozolomide in diffuse intrinsic pontine gliomas: a randomized controlled trial"],"prefix":"10.1007","volume":"146","author":[{"given":"Yousra","family":"Izzuddeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3562-8960","authenticated-orcid":false,"given":"Subhash","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. P.","family":"Haresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayanand","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanth","family":"Giridhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gour Kishore","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"issue":"6","key":"3340_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/adc.80.6.558","volume":"80","author":"DA Walker","year":"1999","unstructured":"Walker DA, Punt JA, Sokal M (1999) Clinical management of brain stem glioma. Arch Dis Child 80(6):558\u2013564","journal-title":"Arch Dis Child"},{"key":"3340_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2012.00205","volume":"2","author":"KE Warren","year":"2012","unstructured":"Warren KE (2012) Diffuse intrinsic pontine glioma: poised for progress. Front Oncol 2:205","journal-title":"Front Oncol"},{"issue":"4","key":"3340_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/neuonc\/noq205","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E et al (2011) Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol 13(4):410\u2013416","journal-title":"Neuro Oncol"},{"issue":"5","key":"3340_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0360-3016(98)00501-X","volume":"43","author":"LR Mandell","year":"1999","unstructured":"Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME et al (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43(5):959\u2013964","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3340_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","volume":"106","author":"A Chassot","year":"2012","unstructured":"Chassot A, Canale S, Varlet P, Puget S, Roujeau T, Negretti L et al (2012) Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol 106(2):399\u2013407","journal-title":"J Neurooncol"},{"issue":"1","key":"3340_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.radonc.2014.01.013","volume":"111","author":"MS Zaghloul","year":"2014","unstructured":"Zaghloul MS, Eldebawy E, Ahmed S, Mousa AG, Amin A, Refaat A et al (2014) Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiother Oncol 111(1):35\u201340","journal-title":"Radiother Oncol"},{"issue":"1","key":"3340_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijrobp.2009.04.031","volume":"77","author":"R Jalali","year":"2010","unstructured":"Jalali R, Raut N, Arora B, Gupta T, Dutta D, Munshi A et al (2010) Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 77(1):113\u2013118","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3340_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1215\/15228517-2008-029","volume":"10","author":"D Frappaz","year":"2008","unstructured":"Frappaz D, Schell M, Thiesse P, Marec-B\u00e9rard P, Mottolese C, Perol D et al (2008) Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial. Neuro-oncology 10(4):599\u2013607","journal-title":"Neuro-oncology"},{"issue":"2","key":"3340_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/pbc.21154","volume":"50","author":"DN Korones","year":"2008","unstructured":"Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J et al (2008) Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study. Pediatr Blood Cancer 50(2):227\u2013230","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"3340_CR10","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/cncr.21534","volume":"104","author":"V Bernier-Chastagner","year":"2005","unstructured":"Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A et al (2005) Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer 104(12):2792\u20132797","journal-title":"Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-019-03340-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:19:03Z","timestamp":1605226743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-019-03340-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3340"],"URL":"https:\/\/doi.org\/10.1007\/s11060-019-03340-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No author has any potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"It was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}